Advertisement
Home »

#VisualAbstract: Temsirolimus Combined with VAC/VI Chemotherapy Did Not Improve Clinical Outcomes of Intermediate-Risk Rhabdomyosarcoma

Jul 19, 2024

ABOUT THE EXPERTS

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


RELEVANT ARTICLES FOR YOU

Advertisement